Cytochroma has announced termination of a license agreement with Mitsubishi Tanabe Pharma (MTPC) thereby regaining rights to all indications of lunacalcipol indications in the US and in Asian territories. The companies mutually decided to ...
Tags: Cytochroma, Mitsubishi Tanabe Pharma, lunacalcipol indications